TO-RAH

Business

TO-RAH leads the era of precision medicine with
next-generation AI analysis technology.
We provide integrated medical services from clinical analysis
to genomic analysis and in vitro diagnostic solutions.

Clinical Analysis/Quality Control
Genomic Analysis
AI-based Automatic
Lung Disease Analysis
We provide real-time severity assessment
and early prediction solutions for major lung diseases
such as pneumonia, pleural effusion, and lung cancer,
utilizing AI technology based on high-resolution
chest X-ray analysis.

Information

With proven technology and performance-based data
in domestic and international medical markets,
TO-RAH is establishing itself as a continuously growing
precision medical technology company.

%

Annual Growth Rate

We are recording remarkable growth of 95%
centered on AI-based analysis technology.
Partnerships

We aim to enter the global market
through cooperation with
global medical networks.
Research/Analysis Cases

Through continuous growth,
we have recorded 90% growth.

News

TO-RAH's technology and vision have reached
a new turning point.
We have confirmed strategic decisions to enhance
corporate value through the shareholders' meeting.
More detailed information can be found in the announcement.